C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.230
+0.040 (1.83%)
Sep 26, 2025, 4:00 PM EDT - Market closed
C4 Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$8.50
Upside
+281.17%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $5 → $10 | Buy | Maintains | $5 → $10 | +348.43% | Sep 23, 2025 |
| Barclays | Barclays | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +348.43% | Sep 23, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $6 | Buy | Reiterates | $6 | +169.06% | Sep 22, 2025 |
| Barclays | Barclays | Buy Initiates $8 | Buy | Initiates | $8 | +258.74% | Sep 17, 2025 |
| Stephens & Co. | Stephens & Co. | Hold → Buy Upgrades $3 → $6 | Hold → Buy | Upgrades | $3 → $6 | +169.06% | Sep 15, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +258.74% | Sep 4, 2025 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $8 → $12 | Hold → Buy | Upgrades | $8 → $12 | +438.12% | Dec 19, 2024 |
| Stephens & Co. | Stephens & Co. | Hold Initiates $4 | Hold | Initiates | $4 | +79.37% | Nov 18, 2024 |
| BMO Capital | BMO Capital | Buy Reiterates $20 | Buy | Reiterates | $20 | +796.86% | Aug 6, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $7 → $8 | Hold | Maintains | $7 → $8 | +258.74% | May 9, 2024 |
| Stifel | Stifel | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +527.80% | May 9, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $1 → $8 | Hold | Maintains | $1 → $8 | +258.74% | Feb 26, 2024 |
| Stifel | Stifel | Strong Buy Reiterates $12 → $13 | Strong Buy | Reiterates | $12 → $13 | +482.96% | Feb 23, 2024 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades $6 | Sell → Hold | Upgrades | $6 | +169.06% | Jan 29, 2024 |
| Stifel | Stifel | Hold → Strong Buy Upgrades $2 → $12 | Hold → Strong Buy | Upgrades | $2 → $12 | +438.12% | Dec 13, 2023 |
| Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades $3 → $1 | Sell → Hold | Upgrades | $3 → $1 | -55.16% | Nov 6, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.